MARIZYME, INC.
Healthcare · Surgical & Medical Instruments & Apparatus · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $645,810 | $233,485 | $210,279 | $197,136 | $0 | $20,187 |
| Operating income | −$34.1M | −$37.3M | −$8.8M | −$5.8M | −$1.1M | −$247,129 |
| Net income | −$65.3M | −$38.2M | −$11.0M | −$5.8M | −$1.1M | −$248,743 |
| Total assets | $22.0M | $38.7M | $66.0M | $47.1M | $28.6M | $28.6M |
| Total liabilities | $26.7M | $21.3M | $18.3M | $1.8M | $270,218 | $42,780 |
| Equity | −$4.7M | $17.4M | $47.7M | $45.3M | $28.3M | $28.6M |
| EPS (diluted) | $-1.44 | $-0.94 | $-0.31 | — | — | — |
| Shares out. | 40.8M | 40.8M | 35.9M | 20.2M | 19.7M | 31.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −5278.1%
- Net margin
- −10118.6%
- Return on equity
- 1402.1%
- Return on assets
- −296.8%
- Return on capital (ROCE)
- −2413.2%
- Liabilities / assets
- 121.2%
- Debt / equity
- —
- Book value / share
- $-0.11
- Revenue growth (YoY)
- 176.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -38.85distress
- Accruals / assets
- −275.5%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2023
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2021
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2021
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Bankruptcy or receivership · Completed an acquisition or dispositionApr 17, 2026
- Prior financials not reliable (restatement)Mar 4, 2025
- Prior financials not reliable (restatement)Jan 31, 2025
- Entered a material agreement · New financial obligationJul 18, 2024
- Regulation FD disclosureMay 6, 2024
- Director / officer changeFeb 6, 2024
- Entered a material agreement · New financial obligation · Unregistered equity saleDec 28, 2023
- Entered a material agreement · New financial obligation · Unregistered equity saleNov 21, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.